This post was just published on ZYX Short Change Alert. There is a small profit in NPSP. Consider booking it before the market close. There is an obvious risk over the weekend. Then consider short selling it again on Monday if it runs up. The buy to cover zone is $30-31.65.
This post was just published on ZYX Short Change Alert. NPSP is a pharma company that is running up on rumors that Shire will by it. In all likelihood these rumors are false. Consider a 20% tranche in the zone of $33.50 to $34.85. The stock is at $34.31 as of
C lick here to see an enlarged chart. An investor who has decided to invest in precious metals has four choices: gold, silver, platinum, and palladium. This article is limited to choosing between gold and silver. There are times when gold is a better investment, and there are times when
This post was just published on ZYX Short Change Alert. RNA is a development stage biotech company. Until yesterday shares had moved up in sympathy with the success at PTCT. Today’s shares are moving up strongly again as investors react to company releasing its presentation to be made at Jeffries on
This post was just published on ZYX Buy Change Alert. We clearly stated yesterday that the plan was to take partial profits on SNN if the stock rose today. In the pre-market, the stock is rising about $4 to $87. Those who took on a full position of 40% with anticipation of taking
Please click here for the annotated chart. Gold broke technical supports, shown on the chart, Tuesday, which could have important implications for the short term. The break is ominous because the support that is now broken was a strong support characterized by a triple bottom. This triple bottom was
This post was just published on ZYX Buy Change Alert. Consider taking advantage of the strength and taking profits on a 10% tranche in the zone of $45 to $46.53. The stock is at $45.05 as of this writing. After this profit taking only 10% of the full core position size
This post was just published on ZYX Buy Change Alert. Consider taking profits on a 10% tranche of JD in the zone of $24.68 to $26.73. The stock is trading at $24.91 as of this writing. After this profit taking 20% of the full core position size will be left.
When a stock is under owned and good news comes, there are plenty of buyers to move the stock up. On the other hand, when a stock is over owned, there aren’t many buyers left to push it higher and even the slightest bit of negative news can push the
This post was just published on ZYX Buy Change Alert. This is suitable for aggressive investors only. After the recent buyout by ZMH of Biomet, it makes all the sense in the world for SYK and SNN to merge to stay competitive in the orthopedics business. There was a report this morning